No TV. No radio. Non-promotional only: companies can communicate with European patients
This article was originally published in Scrip
Executive Summary
Legislative proposals from the European Commission released in December seek to regulate the ways that pharmaceutical companies communicate with patients and the general public. Every time the topic comes up, as it did at a TOPRA (The Organisation for Professionals in Regulatory Affairs) conference in Brussels last week, the spectre of US-style television advertising of prescription drugs is summoned and quickly despatched.